Erratum: The International/Canadian Hereditary Angioedema Guideline (Allergy Asthma Clin Immunol (2020) 16 (33) DOI: 10.1186/s13223-019-0376-8)

Stephen Betschel, Jacquie Badiou, Karen Binkley, Rozita Borici-Mazi, Jacques Hébert, Amin Kanani, Paul Keith, Gina Lacuesta, Susan Waserman, Bill Yang, Emel Aygören-Pürsün, Jonathan Bernstein, Konrad Bork, Teresa Caballero, Marco Cicardi, Timothy Craig, Henriette Farkas, Anete Grumach, Connie Katelaris, Hilary LonghurstMarc Riedl, Bruce Zuraw, Magdelena Berger, Jean Nicolas Boursiquot, Henrik Boysen, Anthony Castaldo, Hugo Chapdelaine, Lori Connors, Lisa Fu, Dawn Goodyear, Alison Haynes, Palinder Kamra, Harold Kim, Kelly Lang-Robertson, Eric Leith, Christine McCusker, Bill Moote, Andrew O'Keefe, Ibraheem Othman, Man Chiu Poon, Bruce Ritchie, Charles St-Pierre, Donald Stark, Ellie Tsai

Research output: Contribution to journalComment/debatepeer-review

Abstract

Following the publication of this article [1], the authors requested to amend the characterisation of lanadelumab from humanised to the correct fully human. Therefore, the fourth paragraph under Recommendation #24 should be amended to read: Lanadelumab (Takeda), a fully human monoclonal antibody against kallikrein, takes approximately 70 days to reach a steady state concentration [110], and is therefore not recommended for STP Similarly, the first paragraph under Recommendation #27 should be amended to read: Lanadelumab is a subcutaneously injectable, fully human, anti-active plasma kallikrein monoclonal antibody (IgG1/K-light chain).

Original languageEnglish (US)
Article number16
JournalAllergy, Asthma and Clinical Immunology
Volume16
Issue number1
DOIs
StatePublished - May 6 2020

All Science Journal Classification (ASJC) codes

  • Immunology and Allergy
  • Immunology
  • Pulmonary and Respiratory Medicine

Fingerprint Dive into the research topics of 'Erratum: The International/Canadian Hereditary Angioedema Guideline (Allergy Asthma Clin Immunol (2020) 16 (33) DOI: 10.1186/s13223-019-0376-8)'. Together they form a unique fingerprint.

Cite this